Author's reply to the Letters to the Editor. Six years duration of adjuvant imatinib in high-risk GIST: more to come

J. Y. Blay, C. Schiffler, S. Chabaud, D. Perolc, A. Le Cesne

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

Accès au document

@article{ea839422304d47849fa37d7af4c4de63,

title = "Author's reply to the Letters to the Editor. Six years duration of adjuvant imatinib in high-risk GIST: more to come",

author = "Blay, {J. Y.} and C. Schiffler and S. Chabaud and D. Perolc and {Le Cesne}, A.",

year = "2024",

month = dec,

day = "1",

doi = "10.1016/j.annonc.2024.09.013",

language = "English",

volume = "35",

pages = "1207--1208",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "12",

}

TY - JOUR

T1 - Author's reply to the Letters to the Editor. Six years duration of adjuvant imatinib in high-risk GIST

T2 - more to come

AU - Blay, J. Y.

AU - Schiffler, C.

AU - Chabaud, S.

AU - Perolc, D.

AU - Le Cesne, A.

PY - 2024/12/1

Y1 - 2024/12/1

UR - http://www.scopus.com/inward/record.url?scp=85210613986&partnerID=8YFLogxK

U2 - 10.1016/j.annonc.2024.09.013

DO - 10.1016/j.annonc.2024.09.013

M3 - Letter

AN - SCOPUS:85210613986

SN - 0923-7534

VL - 35

SP - 1207

EP - 1208

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -